Inspire Medical Systems (INSP) FY2021 results: revenue $233 million, up 102.3% on the year
Inspire Medical Systems, Inc. (INSP) reported revenue of $233 million for fiscal 2021, the year ended 31 December 2021, up 102.3% on the year before. Net income was -$42 million, and diluted earnings per share $-1.54. The figures are the company's own, from the 10-K it filed with the SEC on 15 February 2022.
Revenue
$233 million
+102.3% on the year
FY2016FY2021
Operating margin
-17.1%
-48.7% a year earlier
FY2016FY2021
Net income
-$42 million
FY2016FY2021
Diluted EPS
-$1.54
FY2016FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
-20.1
-53.0
-32.8
Capital expenditure
4.7
2.5
2.7
+90.1%
Free cash flow
-24.8
-55.5
-35.6
Free cash flow margin
-10.6%
-48.1%
-43.4%
Cash from investing
29.1
86.6
-43.6
-66.4%
Cash from financing
14.9
134
2.0
-88.9%
Depreciation and amortisation
1.2
0.8
0.5
+45.0%
Share-based compensation
26.2
12.8
6.2
+104.2%
Diluted shares, weighted
27m
26m
24m
+4.6%
Shares outstanding at period end
27m
27m
24m
+1.3%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
229
230
140
-0.3%
Debt
24.5
24.5
24.5
0.0%
Operating lease liabilities
8.8
5.9
0.0
+49.4%
Other liabilities
32.7
21.1
16.9
+55.5%
Total liabilities and equity
295
281
181
+4.9%
Fixed assets
8.5
5.3
3.0
+59.8%
Investments
9.9
43.8
133
-77.3%
Cash and equivalents
214
191
22.9
+12.6%
Receivables
34.2
25.1
13.1
+36.4%
Inventory
17.2
8.5
5.8
+103.2%
Other assets
10.8
8.0
3.5
+35.2%
Total assets
295
281
181
+4.9%
10-K for the year ended 31 December 2021, filed 15 February 2022: the filing.